کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2203690 1100516 2015 12 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The possible protective effect of simvastatin and pioglitazone separately and in combination on bleomycin-induced changes in mice thin skin
موضوعات مرتبط
علوم زیستی و بیوفناوری علوم کشاورزی و بیولوژیک علوم کشاورزی و بیولوژیک (عمومی)
پیش نمایش صفحه اول مقاله
The possible protective effect of simvastatin and pioglitazone separately and in combination on bleomycin-induced changes in mice thin skin
چکیده انگلیسی


• Bleomycin induces changes in mice thin skin.
• Simvastatin a promising therapeutic agent against bleomycin skin changes.
• Concurrent administration of pioglitazone and simvastatin enhanced their effects.

Bleomycin is a chemotherapeutic agent with side effects especially on skin. Simvastatin is a cholesterol-lowering drug with immunomodulatory, anti-inflammatory, and antifibrotic effects. Pioglitazone is a peroxisome proliferator-activated receptor-γ antidiabetic agent with antiproliferative effects on smooth muscle cells (SMCs), and antioxidant and anti-inflammatory actions. The aim of this study was to investigate the anti-inflammatory and antifibrotic efficiencies of simvastatin and pioglitazone separately and in combination against bleomycin-induced changes in mice thin skin using histological, immunohistochemical, and biochemical techniques. In this study, the mice were divided into seven groups, with each group undergoing treatment for 3 weeks: the control group, group 1 was administered 100 μl of bleomycin, group 2 was administered simvastatin (5 mg/kg/day), group 3 received pioglitazone (10 mg/kg/day), group 4 received simvastatin (5 mg/kg/day) 1 h before bleomycin, group 5 received pioglitazone (10 mg/kg/day) 1 h before bleomycin, and group 6 was administered simvastatin (5 mg/kg/day) and pioglitazone (10 mg/kg/day) 1 h before bleomycin. In group 2, dermal thickening, subcutaneous fat atrophy, degeneration of hair follicles, and thickening of cutaneous vessel walls were observed in addition to a significant increase in caspase-3 reaction, transforming growth factor beta 1 (TGF-β1) expression, and hydroxyproline content. A reversal of the previous findings was markedly observed in group 6 compared with groups 4 and 5. We conclude that the concurrent administration of pioglitazone and simvastatin enhanced their beneficial effects in the reversal of bleomycin-induced changes in mice thin skin.

Figure optionsDownload high-quality image (253 K)Download as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Tissue and Cell - Volume 47, Issue 2, April 2015, Pages 159–170
نویسندگان
, ,